Cargando…
Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy
Glioma stem cells, which are sub-populations of tumor cells, are responsible for resistant responses to radiotherapy and chemotherapy after surgery. Targeting resistant glioma stem cell sub-populations might present a novel means to prevent tumor recurrence. Due to the high expression of transferrin...
Autores principales: | Sun, Ting, Wu, Haibin, Li, Yanyan, Huang, Yulun, Yao, Lin, Chen, Xionghui, Han, Xiaoxiao, Zhou, Youxin, Du, Ziwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650354/ https://www.ncbi.nlm.nih.gov/pubmed/29088799 http://dx.doi.org/10.18632/oncotarget.20165 |
Ejemplares similares
-
Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy
por: Sun, Ting, et al.
Publicado: (2016) -
Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
por: Sun, Ting, et al.
Publicado: (2019) -
miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells
por: Wu, Zhiwu, et al.
Publicado: (2022) -
Transferrin-Conjugated
PLGA Nanoparticles for Co-Delivery
of Temozolomide and Bortezomib to Glioblastoma Cells
por: Ramalho, Maria João, et al.
Publicado: (2023) -
G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells
por: Cao, Yufei, et al.
Publicado: (2023)